The Hyper IgM Foundation and the Wiskott-Aldrich Foundation’s first-ever international X-Linked Carrier Survey was developed in collaboration with the Primary Immune Deficiency Treatment Consortium (PIDTC) and the Immune Deficiency Foundation (IDF).
"A study assessing the physical health and psychosocial well-being of female carriers of Wiskott-Aldrich syndrome (WAS) and X Linked Hyper IgM Syndrome (X-HIGM)"
Developed with immunologists who are experts in primary immunodeficiency diseases, including Wiskott-Aldrich syndrome (WAS) and X Linked Hyper IgM Syndrome (X-HIGM), this survey aimed to learn more about the reported health outcomes of Carriers of WAS and X-HIGM and how this affects individuals’ lives, including diagnosis, along with carries’ overall well-being and quality of life.
Carriers of X-HIGM and WAS are very rare and have never been part of a detailed international exploratory survey before. Therefore, participation was particularly important for all families affected by Hyper IgM and Wiskott-Aldrich syndromes as the survey results helped increase what is currently known about carriers of X-HIGM and WAS.
Receive news and helpful resources to your cell phone or inbox. You can change or cancel your subscription at any time.
The Immune Deficiency Foundation improves the diagnosis, treatment, and quality of life for every person affected by primary immunodeficiency.
We foster a community that is connected, engaged, and empowered through advocacy, education, and research.
Combined Charity Campaign | CFC# 66309